NCT07789574
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07789574
Title Efficacy of Asciminib in Chronic Phase CML Patients With T315I Mutations (ESTIMATION)
Acronym ESTIMATION
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Thomas Ernst, Prof. Dr. med.
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Uniklinik der RWTH Aachen RECRUITING Aachen 52074 Germany Details
Charite CVK NOT_YET_RECRUITING Berlin 13353 Germany Details
Klinikum Chemnitz gGmbH NOT_YET_RECRUITING Chemnitz 09113 Germany Details
Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden NOT_YET_RECRUITING Dresden 01307 Germany Details
Universitätsklinikum Hamburg-Eppendorf NOT_YET_RECRUITING Hamburg 20246 Germany Details
Medizinische Hochschule Hannover NOT_YET_RECRUITING Hanover 30625 Germany Details
Universitätsklinikum Jena RECRUITING Jena 07747 Germany Details
Universitätsklinikum Leipzig AöR RECRUITING Leipzig 04103 Germany Details
Medizinische Fakultät Mannheim der Universität Heidelberg RECRUITING Mannheim 68167 Germany Details
Universitätsklinikum Ulm RECRUITING Ulm 89081 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field